Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Molecular Neurodegeneration volume 18, Article number: 69 (2023)
Molecular Neurodegeneration (2023) 18:41
The original article  contained errors in the Funding section. The correct Funding information can be viewed ahead:
This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Ministry of Science, ICT and Future Planning (MSIP) (NRF-2020R1A5A1019023 to Y.T.K., NRF-2021R1A2B5B03002614 to Y.T.K., NRF-2020R1A5A1019023 to Y.H.S., and NRF-2022R1A2C1004913 to Y.H.S.), the Korea Dementia Research Project (HU21C0071 to Y.H.S.), and the Ministry of Education (RS-2023-00243474 to E.J.B.). This work was also supported by Korea Drug Development Fund (KDDF) (RS-2022-00166787 to K.W.S.).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13024-023-00630-7.
About this article
Cite this article
Lee, J., Sung, K.W., Bae, EJ. et al. Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology. Mol Neurodegeneration 18, 69 (2023). https://doi.org/10.1186/s13024-023-00661-0